These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23681745)

  • 1. ERBB4 confers metastatic capacity in Ewing sarcoma.
    Mendoza-Naranjo A; El-Naggar A; Wai DH; Mistry P; Lazic N; Ayala FR; da Cunha IW; Rodriguez-Viciana P; Cheng H; Tavares Guerreiro Fregnani JH; Reynolds P; Arceci RJ; Nicholson A; Triche TJ; Soares FA; Flanagan AM; Wang YZ; Strauss SJ; Sorensen PH
    EMBO Mol Med; 2013 Jul; 5(7):1087-102. PubMed ID: 23681745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.
    Kang HG; Jenabi JM; Zhang J; Keshelava N; Shimada H; May WA; Ng T; Reynolds CP; Triche TJ; Sorensen PH
    Cancer Res; 2007 Apr; 67(7):3094-105. PubMed ID: 17409416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.
    Li J; You T; Jing J
    Cell Prolif; 2014 Apr; 47(2):152-60. PubMed ID: 24517182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.
    Satterfield L; Shuck R; Kurenbekova L; Allen-Rhoades W; Edwards D; Huang S; Rajapakshe K; Coarfa C; Donehower LA; Yustein JT
    Int J Cancer; 2017 Nov; 141(10):2062-2075. PubMed ID: 28748534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal adhesion kinase confers pro-migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma.
    Steinestel K; Trautmann M; Jansen EP; Dirksen U; Rehkämper J; Mikesch JH; Gerke JS; Orth MF; Sannino G; Arteaga MF; Rossig C; Wardelmann E; Grünewald TGP; Hartmann W
    Mol Oncol; 2020 Feb; 14(2):248-260. PubMed ID: 31811703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.
    Potratz J; Tillmanns A; Berning P; Korsching E; Schaefer C; Lechtape B; Schleithoff C; Unland R; Schäfer KL; Müller-Tidow C; Jürgens H; Dirksen U
    Mol Oncol; 2016 May; 10(5):677-92. PubMed ID: 26739507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth.
    Moore C; Parrish JK; Jedlicka P
    PLoS One; 2017; 12(5):e0178028. PubMed ID: 28542597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma.
    Krook MA; Nicholls LA; Scannell CA; Chugh R; Thomas DG; Lawlor ER
    Mol Cancer Res; 2014 Jun; 12(6):953-64. PubMed ID: 24651452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells.
    Passacantilli I; Frisone P; De Paola E; Fidaleo M; Paronetto MP
    Nucleic Acids Res; 2017 Dec; 45(21):12270-12284. PubMed ID: 29036465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HDGF-ALCAM axis promotes the metastasis of Ewing sarcoma via regulating the GTPases signaling pathway.
    Yang Y; Ma Y; Gao H; Peng T; Shi H; Tang Y; Li H; Chen L; Hu K; Han A
    Oncogene; 2021 Jan; 40(4):731-745. PubMed ID: 33239755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome profiling of Ewing sarcomas - treatment resistance pathways and IGF-dependency.
    Chen Y; Hesla AC; Lin Y; Ghaderi M; Liu M; Yang C; Zhang Y; Tsagkozis P; Larsson O; Haglund F
    Mol Oncol; 2020 May; 14(5):1101-1117. PubMed ID: 32115849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
    Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM
    Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.
    Hong SH; Tilan JU; Galli S; Izycka-Swieszewska E; Polk T; Horton M; Mahajan A; Christian D; Jenkins S; Acree R; Connors K; Ledo P; Lu C; Lee YC; Rodriguez O; Toretsky JA; Albanese C; Kitlinska J
    Oncotarget; 2015 Mar; 6(9):7151-65. PubMed ID: 25714031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway.
    Kamura S; Matsumoto Y; Fukushi JI; Fujiwara T; Iida K; Okada Y; Iwamoto Y
    Br J Cancer; 2010 Jul; 103(3):370-81. PubMed ID: 20606682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-124 represses the mesenchymal features and suppresses metastasis in Ewing sarcoma.
    Li Y; Shao G; Zhang M; Zhu F; Zhao B; He C; Zhang Z
    Oncotarget; 2017 Feb; 8(6):10274-10286. PubMed ID: 28055964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.
    Nan X; Wang J; Cheng H; Yin Z; Sheng J; Qiu B; Lau CC; Yustein JT; Zhao H; Wong STC
    Cancer Lett; 2020 Jan; 469():195-206. PubMed ID: 31672491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
    Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
    Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of TWIST1 contributes to Ewing sarcoma metastasis.
    Choo S; Wang P; Newbury R; Roberts W; Yang J
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28873262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.